Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Reddit
RDDT
|
+$196M |
| 2 |
Nike
NKE
|
+$183M |
| 3 |
Alibaba
BABA
|
+$172M |
| 4 |
Shopify
SHOP
|
+$167M |
| 5 |
TSMC
TSM
|
+$154M |
Top Sells
| 1 |
Palantir
PLTR
|
+$1.18B |
| 2 |
Microsoft
MSFT
|
+$678M |
| 3 |
Meta Platforms (Facebook)
META
|
+$350M |
| 4 |
Apple
AAPL
|
+$202M |
| 5 |
Micron Technology
MU
|
+$202M |
Sector Composition
| 1 | Technology | 20.89% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 14.08% |
| 4 | Industrials | 8.96% |
| 5 | Financials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Solid Biosciences
SLDB
$408M
| $330K | ﹤0.01% |
82,493
+9,281
| +13% | +$37.1K |
|
3002
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.43B
| $329K | ﹤0.01% |
+3,523
| New | +$329K |
|
3003
Ohio Valley Banc Corp
OVBC
$173M
| $329K | ﹤0.01% |
13,575
-400
| -3% | -$9.68K |
|
3004
Inuvo
INUV
$49.9M
| $328K | ﹤0.01% |
50,715
+4,335
| +9% | +$28K |
|
3005
Mativ Holdings
MATV
$666M
| $326K | ﹤0.01% |
+29,912
| New | +$326K |
|
3006
Apyx Medical
APYX
$74.5M
| $326K | ﹤0.01% |
206,195
+2,900
| +1% | +$4.58K |
|
3007
iShares Core MSCI Total International Stock ETF
IXUS
$49.2B
| $324K | ﹤0.01% |
+4,900
| New | +$324K |
|
3008
First Trust RBA American Industrial Renaissance ETF
AIRR
$5.33B
| $324K | ﹤0.01% |
+4,200
| New | +$324K |
|
3009
Cambium Networks
CMBM
$19.8M
| $324K | ﹤0.01% |
501,800
+363,399
| +263% | +$234K |
|
3010
SPDR S&P Semiconductor ETF
XSD
$1.48B
| $323K | ﹤0.01% |
1,300
-1,100
| -46% | -$273K |
|
3011
Zura Bio
ZURA
$134M
| $323K | ﹤0.01% |
129,114
+65,214
| +102% | +$163K |
|
3012
TTEC Holdings
TTEC
$179M
| $321K | ﹤0.01% |
64,322
+49,600
| +337% | +$248K |
|
|
ACCS
3013
ACCESS Newswire Inc.
ACCS
$42.1M
| $319K | ﹤0.01% |
35,738
+300
| +0.8% | +$2.68K |
|
3014
Intellicheck
IDN
$108M
| $319K | ﹤0.01% |
114,000
+9,900
| +10% | +$27.7K |
|
|
WW
3015
DELISTED
WW International
WW
| $319K | ﹤0.01% |
+250,838
| New | +$319K |
|
|
SPYU
3016
MAX S&P 500 4x Leveraged ETN
SPYU
$414M
| $318K | ﹤0.01% |
+6,800
| New | +$318K |
|
|
GB
3017
DELISTED
Global Blue Group Holding
GB
| $317K | ﹤0.01% |
45,800
+19,600
| +75% | +$136K |
|
3018
Accenture
ACN
$152B
| $317K | ﹤0.01% |
+900
| New | +$317K |
|
3019
PJT Partners
PJT
$4.37B
| $316K | ﹤0.01% |
+2,000
| New | +$316K |
|
3020
Jerash Holdings
JRSH
$44.1M
| $315K | ﹤0.01% |
92,240
+19,800
| +27% | +$67.7K |
|
3021
Live Ventures
LIVE
$54.1M
| $315K | ﹤0.01% |
33,799
-2,070
| -6% | -$19.3K |
|
3022
Virtus Investment Partners
VRTS
$1.31B
| $315K | ﹤0.01% |
1,429
-3,372
| -70% | -$744K |
|
3023
Ebang International Holdings
EBON
$25.8M
| $315K | ﹤0.01% |
55,027
+8,414
| +18% | +$48.1K |
|
3024
BTCS Inc
BTCS
$213M
| $315K | ﹤0.01% |
127,391
+90,171
| +242% | +$223K |
|
|
ZBIO
3025
Zenas BioPharma, Inc. Common Stock
ZBIO
$833M
| $314K | ﹤0.01% |
+38,400
| New | +$314K |
|